Bryan, Garnier & Co

🌐 Bryan, Garnier & Co acts as Sole Financial Advisor to Francisco Partners on its investment in Orisha, a leading European Vertical Market Software platform. More about the deal: https://lnkd.in/eJEVaWYa Orisha currently offers highly specialised vertical software solutions to over 40,000 customers. The investment from Francisco Partners, alongside TA and Orisha management, will further drive Orisha’s growth journey, solidifying its industry leadership. 🤝 This transaction is another testimony of Bryan Garnier’s expertise in supporting software sector players and private equity-led transactions. Previous notable transactions include the sale of Diapason to PSG Equity, the sale of Sinari to Bridgepoint Development Capital, the investment of Keensight Capital in e-Attestations.com, the sale of Nomadia to Hg Capital and The Carlyle Group’s investment in LACOUR GROUP. More about the deal: https://lnkd.in/eJEVaWYa   Thibaut De Smedt, Stanislas de GMELINE, Valentin Werlé, Kevin Akbaraly, Rafael Ney #Orisha #ERP #Vertical #Software 

Reflecting on being a Healthcare Investment Banking Partner at a boutique investment bank: https://lnkd.in/eMg2XY32 Paul started working at Bryan, Garnier & Co just over three years ago as a Managing Director for the Healthcare Investment Banking team, with pharma and Medtech as his fields of expertise. In March 2024, he was promoted to Partner. We sat down with Paul as part of our Employee Growth Stories to learn more about his responsibilities and his advice for aspiring bankers. 🔗 Read Paul’s full story here: https://lnkd.in/eMg2XY32 #CareerDevelopment #BryanGarnier #InvestmentBanking #GrowthMindset 

📈 Nike vs Adidas – who comes out on top? https://lnkd.in/dGMS3UB7 👟 While the popularity of Adidas' sneakers and Euro 2024 sponsorship are poised to help the German sportswear brand achieve its highest profit margin in three years, Nike is facing challenges with its unexpected sales drop. What has caused this major shift? 💬 Senior News Reporter Linda Pasquini at Reuters spoke with Cédric Rossi, NextGen Consumer BG IRIS Research Analyst at Bryan Garnier to examine the market dynamics and competitive landscape impacting Nike and benefiting Adidas. 🔗 Read more about Cedric Rossi's insights here: https://lnkd.in/dGMS3UB7 

🌿 Did you know that the global complementary and alternative medicine market is expected to reach USD 694.22 billion by 2030? https://lnkd.in/epprYTpH As a century-old leader in homeopathy, Boiron has served millions of patients worldwide, offering them a natural alternative that resonates with healthcare professionals and patients alike. 🎥 We sat down with Boiron's CEO to discuss their rich history, commitment to quality and innovation, and exciting expansion into the U.S. market with EW Healthcare Partners. 📺 Watch the latest episode of “BG Growth Series” to learn more about Boiron's journey and their transformative impact on global healthcare: https://lnkd.in/epprYTpH #NaturalMedicine #HealthcareInvestment #Boiron #BryanGarnier Olivier Garnier, Hervé Ronin, Raphaël Bidaut, Hamza Falah, Jonathan Pavillard, Léa Maufras-Lenoël

Exciting collaborations in Europe and China and prestigious awards - CARBIOS' growth is among the most exciting stories we're proud to share with you! https://lnkd.in/epyXMfak Bryan Garnier has advised Carbios through four strategic capital raises, including a €141 million capital raise last year. Some highlights that have taken place at the company since include: 🧴 An award-winning collaboration with the L’OCCITANE Group  🧵 Joining forces with leading circularity technology firm TOMRA Textiles, closing fashion's circularity gap   🤝 A long-term PET biorecycling partnership with the Zhink Group for enzymatically recycled rPET in Asia 🏆1st prize in the "So French So Innovative" Award at InnoEX 2024 in Hong Kong 🎥 Learn more about Carbios in our "BG Growth Series" episode where Emmanuel LADENT 🌏 CEO CARBIOS and Board President Philippe Pouletty discuss Carbios' pioneering initiatives in advancing sustainability and innovation through plastic recycling. 🔗 See the full episode here: https://lnkd.in/epyXMfak Olivier Garnier, Christophe Alleman, Olivier Beaudouin, Jerome Guyot, Camille Dubroc #Carbios #Sustainability #PlasticRecycling #BGGrowthSeries #BryanGarnier

🗝️ What are some key takeaways from M&A internships? Meet some of our interns, whose journey at Bryan Garnier has been a gateway into a lucrative career in investment banking. Here's to nurturing talent and fostering a culture of continuous growth! Check out our current internship opportunities here: https://lnkd.in/eAsvKhm #GrowthMindset #InternExcellence #BryanGarnierGrowth #UnleashingPotential Jérôme Lenay, Nicolas Plovier, Candice Curlier, Willy Guilleminot, Malek Sabri, Mattéo Delalande, Théophile Larbre Delmas, Guillaume Thomazeau, Thomas Hynes, Mohamed El Hachemi, Valentin C.

💻 Join us on Tuesday 23rd July to hear about the latest developments in secondaries and the evolution of company-led liquidity. 🔗 https://lnkd.in/eaE7eh9z  The European secondary market is quickly gaining popularity and attracting both new and existing investors. This shift indicates the maturation of venture capital and reflects a transformative shift as stakeholders adapt to new liquidity needs and market dynamics. Learn more in our upcoming White Paper "Demystifying company-led secondaries" and join our exclusive accompanying webinar on 23rd July where former-NotSoLiquid co-founders David and Pierre delve into: 📈 The market overview: Navigating VC secondaries in 2024 🎯 Company-led liquidity strategies and best practices 💰 Use cases and investor landscape Don’t miss this opportunity to learn more about this topic in our webinar – register now 🔗 https://lnkd.in/eaE7eh9z #VentureCapital #SecondaryMarkets #WhitePaper #Webinar #BryanGarnier

🛰️ How will Amazon's Kuiper overcome the challenges in its race against SpaceX's Starlink? 💬 BG IRIS Research Associate Antoine Lebourgeois, CFA recently shared insights with Capucine Cousin in L'AGEFI about the recent approval for deploying Amazon’s Kuiper satellites in France. Find out what Amazon needs to do to catch up to SpaceX! 🔗 Explore the key takeaways in English here: https://lnkd.in/eWgKUqBu 📰 For French speakers, read the article here: https://lnkd.in/eEVNwUhv #SpaceIndustry #Satellites #SpaceX #Amazon #BGIRIS #LAGEFI

Did you know that home haemodialysis patients can save up to 52 days per year through reduced recovery, travel, and appointment wait times? https://lnkd.in/ecmDY-VW  ⚕️ Having administered over 1 million treatments with their S3 monitor and currently serving 1100 home patients daily, PHYSIDIA is at the forefront of home haemodialysis solutions. In our interviews with Physidia’s leaders and investors, we explored their dedication to transforming healthcare perceptions, enhancing patient quality of life, and effectively managing conditions. 🌎 Looking ahead, Physidia is expanding into new European, Middle Eastern, and US markets, advancing R&D for next-generation devices, and leveraging data to improve home care. Welcome to the “BG Growth Series”, where entrepreneurs tell us about their inspiring stories, share invaluable insights, and offer practical tips to navigate the growth journey. 🔗 See the full episode here: https://lnkd.in/ecmDY-VW  Didier Candelot, Nicolas P., Julien Dolivet, Rory Devlin, Charles Nantois Olivier Garnier, Hervé Ronin, Paul de Mestier, Raphaël Bidaut, Mark (Min-Woo) Hong #HomeDialysis #HealthcareInnovation #Physidia #BryanGarnier #PatientCare

🚀 How do you turn innovation into world-changing success? https://lnkd.in/ek_bBnJB We had the privilege to interview Anne Glover, CEO and Co-Founder of Amadeus Capital Partners, about her journey in venture capital, covering topics such as: 🎯 Mastering your trade  📉 Creating value in tough market conditions  🌱 The maturity of the VC ecosystem in the US compared to the EU Anne’s insights are a reminder of the importance of persistence in driving innovation. #VentureCapital #Entrepreneurship #Innovation #Leadership #BryanGarnier